Gale.cengage.co.uk

Graham & Whiteside
Australia • Brazil • Japan • Korea • Mexico • Singapore • Spain • United Kingdom • United States Major Pharmaceutical and Biotechnology Companies of the World 2009
Africa (South of the Sahara)
Malaysia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 Angola . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Mongolia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133 Benin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Myanmar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134 Botswana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Nepal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134 Burkina Faso . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 New Zealand . . . . . . . . . . . . . . . . . . . . . . . . . . 134 Cape Verde . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 North Korea . . . . . . . . . . . . . . . . . . . . . . . . . . . 136 Ethiopia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Pakistan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136 Gabon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Papua New Guinea . . . . . . . . . . . . . . . . . . . . . 138 Ghana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 People’s Republic of China . . . . . . . . . . . . . . . 138 Ivory Coast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Philippines . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157 Kenya . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Singapore . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161 Lesotho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 South Korea . . . . . . . . . . . . . . . . . . . . . . . . . . . 166Sri Lanka . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174 Madagascar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Taiwan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175 Malawi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Thailand . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178 Mali . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Vietnam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180 Mauritius . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Mozambique . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Eastern Europe and the Commonwealth of Indepen-
Niger . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 dent States
Nigeria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Armenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182 Senegal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Belarus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182 Seychelles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Bosnia and Herzegovina . . . . . . . . . . . . . . . . . 183 South Africa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Croatia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 Swaziland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Georgia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184 Togo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Kazakhstan . . . . . . . . . . . . . . . . . . . . . . . . . . . 184 Uganda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Macedonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 Zambia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Montenegro . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 Zimbabwe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Russia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 Arab World
Serbia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189Ukraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190 Algeria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Uzbekistan . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 Bahrain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16Egypt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Gaza and West Bank . . . . . . . . . . . . . . . . . . . . . 22 Austria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 Iraq . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Belgium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196 Jordan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Bulgaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203 Kuwait . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Cyprus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204 Lebanon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Czech Republic . . . . . . . . . . . . . . . . . . . . . . . . 205 Libyan Arab Jamahiriya . . . . . . . . . . . . . . . . . . . 30 Denmark . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209 Mauritania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Estonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216 Morocco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Finland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217 Oman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221 Qatar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249 Saudi Arabia . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Greece . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275 Sudan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 Hungary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279 Syrian Arab Republic . . . . . . . . . . . . . . . . . . . . . 42 Iceland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284 Tunisia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Israel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285 United Arab Emirates . . . . . . . . . . . . . . . . . . . . 44 Italy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291 UAE (Abu Dhabi) . . . . . . . . . . . . . . . . . . . . . . . . 44 Latvia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301 UAE (Dubai) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Liechtenstein . . . . . . . . . . . . . . . . . . . . . . . . . . 302 UAE (Fujairah) . . . . . . . . . . . . . . . . . . . . . . . . . . 46 Lithuania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302 UAE (Ras Al Khaimah) . . . . . . . . . . . . . . . . . . . . 46 Luxembourg . . . . . . . . . . . . . . . . . . . . . . . . . . 303 UAE (Sharjah) . . . . . . . . . . . . . . . . . . . . . . . . . . 46 Malta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303 Yemen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 Monaco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303Netherlands . . . . . . . . . . . . . . . . . . . . . . . . . . . 304 Asia and Australasia
Norway . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311 Australia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 Poland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314 Bangladesh . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 Portugal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 322 Hong Kong SAR . . . . . . . . . . . . . . . . . . . . . . . . . 58 Republic of Ireland . . . . . . . . . . . . . . . . . . . . . 327 India . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 Romania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 331 Indonesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94 Slovakia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 333 Iran . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 Slovenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 334 Japan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 Spain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 336 Sweden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 352 Chile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 416 Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 Colombia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 418 Turkey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 374 Costa Rica . . . . . . . . . . . . . . . . . . . . . . . . . . . . 420 UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 376 Ecuador . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421El Salvador . . . . . . . . . . . . . . . . . . . . . . . . . . . 422 Latin America
Guatemala . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422 Argentina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 399 Guyana . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422 Belize . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 402 Honduras . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422 Bolivia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 402 Mexico . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422 Brazil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 402 Nicaragua . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429 CARIBBEAN - Antigua and Barbuda . . . . . . . . 412 Panama . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429 CARIBBEAN - Aruba . . . . . . . . . . . . . . . . . . . . 412 Paraguay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429 CARIBBEAN - Bahamas . . . . . . . . . . . . . . . . . 412 Peru . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 430 CARIBBEAN - Barbados . . . . . . . . . . . . . . . . . 413 Suriname . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 431 CARIBBEAN - Bermuda . . . . . . . . . . . . . . . . . . 413 Uruguay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 431 CARIBBEAN - Cayman Islands . . . . . . . . . . . . 413 Venezuela . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432 CARIBBEAN - Dominican Republic . . . . . . . . . 413CARIBBEAN - Grenada . . . . . . . . . . . . . . . . . . 414 North America
CARIBBEAN - Jamaica . . . . . . . . . . . . . . . . . . 414 Canada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 434 CARIBBEAN - Netherlands Antilles . . . . . . . . . 415 USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440 CARIBBEAN - Puerto Rico . . . . . . . . . . . . . . . . 415CARIBBEAN - St Lucia . . . . . . . . . . . . . . . . . . 415 CARIBBEAN - St Vincent and the Grenadines . 416 Alphabetical Index . . . . . . . . . . . . . . . . . . . . . 471 CARIBBEAN - Trinidad and Tobago . . . . . . . . . 416 Index by Country . . . . . . . . . . . . . . . . . . . . . . 495 WAKO PURE CHEMICALS INDUSTRIES . . . 00953
Rhythm, Kikuron, Kolberon, Tocks, Aoi Umi, Hakubiso, Mori TORII PHARMACEUTICAL CO LTD
VITAL-NET INC
Branch Offices: Tokyo; New York, USA; London, UK Address: 3-4-1 Nihonbashi-Honcho, Chuo-ku, Tokyo 103- Former name: Sun-S Inc
Subsidiary Companies: (100% owned unless stated): Address: 1-1 Ohtemachi, Aoba-ku, Sendai 980-8581 HOKURIKU MEDICAL SERVICE CO LTD; Taiyo Sangyo Co Ltd; Tomix Co Ltd; TOYAMA EUROPE LTD (UK); Toyama Kouei Co Ltd; TOYAMA USA Inc (USA); White Public Rela- Board of Directors: Norihiko Matsuo (President), Hiroshi Imai Board of Directors: Jun Suzuki (Chairman), Ken Suzuki (Rep- (Managing Director/Chief Pharmaceutical Marketing), Yuji Kagohashi (Director/Chief of R&D & Production), Hiroshi PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals Kanaya (Executive Deputy President/Chief of Corporate Planning & Admin), Masanori Wada (Director/QA) Senior Executives: Tadashi Kadota (Corporate Auditor), Financial Information: 2008: Consolidated Yoshiaki Otsuka (Corporate Auditor), Yoshiyuki Taniguchi Principal Shareholders: Hikoji Suzuki (6.7%); Suzuhiko Ltd (Corporate Auditor), Hideo Yamaguchi (Corporate Auditor) Sales turnover
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals Parent Company: Japan Tobacco Inc, Japan (00864) Financial Information: Consolidated figures Sales turnover
Principal Shareholders: Japan Tobacco Inc (53.5%) TRANS GENIC INC
Address: 3-14-3 Minami-Kumamoto, Kumamoto-shi, Ku- Sales turnover
WAKAMOTO PHARMACEUTICAL CO LTD
Board of Directors: Satoru Endo (Auditor), Toshio Kajima Address: 1-5-3 Nihonbashi-Muromachi, Chuo-ku, Tokyo (Auditor), Masahiro Koreishi (President and Chief Execu- tive Officer), Yasuhiko Matsuo (Internal Auditor), Michita Satoh (Director), Jun Tanaka (Executive Director), Ken-ichi Website: www.wakamoto-pharm.co.jpBoard of Directors: Kiyoaki Makita (Chairman), Takashi Ishii PRINCIPAL ACTIVITIES: Analysis of genes and genetics infor- TOWA PHARMACEUTICAL CO LTD
Principal Banks: Shoko Chukin Bank; The Bank of Tokyo- PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals Address: 2-11 Shinbashi-cho, Kadoma 571-8580, Osaka Principal Shareholders: Kissei Pharmaceutical (9.5%); Brast- Board of Directors: Itsuro Yoshida (President) PRINCIPAL ACTIVITIES: Manufacture of drugs for respiratory Financial Information: Consolidated figures Branch Offices: Osaka; Hannan; Nagoya; Takarazuka; Sales turnover
Sales turnover
Principal Shareholders: Yoshida Jimsho (17.4%); Yoshida Kosan (11.6%); Yoshida Kikaku (8.8%); Itsuro Yoshida Date of Establishment: April 1957No of Employees: 1,125 (group)Financial Information: Consolidated figures TSUMURA & CO
WAKO PURE CHEMICALS INDUSTRIES LTD
Sales turnover
Address: 2-17-11 Akasaka, Minato-ku, Tokyo 107-8521 Address: 3-1-2 Doshomachi, Chuo-ku, Osaka 540-8605 Board of Directors: Junichi Yoshii (President) PRINCIPAL ACTIVITIES: Manufacture and sale of pharmaceu- Board of Directors: Hajime Ikezoe (President), Syunrou Kawa- ticals, quasi-pharmaceuticals and toiletries mura (Senior Managing Executive Officer), Eisuke Kimura Branch Offices: Sapporo; Sendai; Tokyo; Nagoya; Osaka; (Managing Executive Officer/GM Corporate Production/QA), Yokohama; Shizuoka; Kyoto; Kobe; Takamatsu; Tachikawa; Takeo Matsumoto (Managing Executive Officer/GM Corpo- rate Admin & Personnel), Norimichi Ueno (Senior Managing TOYAMA CHEMICAL CO LTD
Executive Officer), Yoshiharu Watabiki (Senior Managing Address: 3-2-5 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023 Senior Executives: Shigeru Fukushima (Corporate Auditor), Principal Shareholders: Japan Trustee Services Bank Eio Okayama (Corporate Auditor), Toyoji Yoshida (Corporate (12.6%); Master Trust Bank of Japan (5.7%) PRINCIPAL ACTIVITIES: Provision of laboratory chemicals, Board of Directors: Katsuhiko Nakano (Chairman), Masuji specialty chemicals and diagnostic reagents for genetic Sugata (President), Shinichiro Inushima (Director), Shozo Financial Information: Consolidated figures engineering research, tissue culture, measurement of Kakimoto (Director), Yoshiharu Murotani (Director), Akira environmental pollutants, immunological research, chro- Ohira (Director), Hideo Sanada (Director/Senior Executive matography, organic syntheses and biochemical research Officer), Yukio Yanagida (Director), Hiroichi Yoshida (Direc- Sales turnover
Subsidiary Companies: (100% owned unless stated): Wako Chemicals GmbH (Germany); Wako Chemicals USA Inc PRINCIPAL ACTIVITIES: Manufacture and sale of pharmaceu- ticals, antibiotics and industrial chemicals Trade Names: Ozex, Tomiron, Pentcillin, Tazocin, Cefoper- azin, Tomiporan, Luprac, Flucam, Baxo, Abovis, Pirocut, 03192 SIGMA PHARMACEUTICAL PLC
Indurgan, Lodine SR(TM), Mecloderm, Mecloderm F, Mep- Principal Law Firm: Fasken Martineau Stringer Saul LLP; tid(TM), Midon, Monocid*, PACIS(R), PENTASA(R), PROA- Board of Directors: Gerald Corbett (Chairman), Garry Watts MATINE(R), Reminyl(TM), Rentibloc(R), Rentylin(R), SECOND (Chief Executive Officer), Richard Adam (Non-Executive LOOK, Sertagyn, Testimonia, Trandate, Trizivir(R), VERA- Director), Ian Adamson (Managing Director, Europe and Americas), Peter Johnson (Non-Executive Director), Mark Subsidiary Companies: (100% owned unless stated): Shire Moran (Finance Director), Peter Read (Non-Executive Direc- BioChem, Inc (Canada); Shire Deutschlaand GmbH & Co KG Principal Shareholders: HBM BioVentures (Cayman) Ltd (Germany); Shire France SA (France); Shire Human Generic Management: Maria Buxton-Smith (Company Secretary), Therapies (USA); Shire Italia SpA (Italy); Shire Pharma- Paul Doherty (Head of Corporate Affairs), Jan Young (Head ceutical Contracts Ltd (Singapore); Shire Pharmaceuticals Financial Information: Consolidated figures Group Ltd; Shire Pharmaceuticals Iberica SL (Spain); Shire PRINCIPAL ACTIVITIES: Manufacture and distribution of Pharmaceuticals Ireland Ltd (Republic of Ireland); Shire US healthcare products, barrier contraceptives, footwear and Manufacturing Inc (USA); Shire, Inc (USA) Sales turnover
Mergers and Acquisitions: In Novebember 2007 the Group acquired the business and certain assets of Vasyli Australia Pty Ltd, Vasyli (NZ) Ltd, and Vasyli UK Ltd.
Major Products: Scholl footcare and footware, Durex con- Principal Shareholders: Legal & General Group plc (5.26%) doms, Regent Biogel surgical gloves, Marigold household and industrial gloves, OTC products including Syndol, Financial Information: 2006: Consolidated Figures; GAAP.
Cuprofen, Resolve, Ralgex, Tubigrip and wound manage- SOURCE BIOSCIENCE PLC
Former name: Medical Solutions plc
Trade Names: Adapta, Avanti, Cuprofen, Derbac, Diana, Dio- Address: 1 Orchard Place, Nottingham Business Park, Not- calm, Dr Scholl, Due In Uno, Durex, Durex Sensation, Eu- lactol, Fresh Step, Full Marks, Gelactiv, Hydra-Gel, Meltus, Mister Baby, Natruclear, Paramol, Party Feet, Performa, Pescura, Play, Pleasuremax, ProSport, Ralgex, Remegel, Resolve, Sauber, Scholl, Scholl Flight Socks, Syndol, Wood- Board of Directors: Laurie Turnbull (Chairman), Dr Nick Ash Subsidiary Companies: (100% owned unless stated): LIG (Managing Director), Dr Sue Foden (Non-Executive Direc- China BV (Netherlands); London International GmbH (Ger- tor), Dr Nick Leaves (Operations Director), Robin Slinger many); London International Group Ltd; London International (Non-Executive Director), Dr Thomas Weaver (Commercial Norway A/S (Norway); LRC North America Inc (USA); LRC Products Ltd; LRC Products Ticaret ve Pazarlama Ltd Sirketi PRINCIPAL ACTIVITIES: The Group is a holding company (Turkey); New Bridge Holdings BV (Netherlands); NV SSSL SIGMA PHARMACEUTICAL PLC
and the principal activities of the subsidiaries are the mar- Healthcare Belgium SA (Belgium); Qingdao London Durex Address: 1 Colonial Way, Imperial Way, Watford WD2 4LA keting and sale of microscopy hardware and software Company Limited (People’s Republic of China); Scholl Con- and image analysis and management systems, develop- sumer Products Ltd; Scholl (Investments) Ltd; Scholl Ltd; ment of intellectual property in cancer diagnosis/prognosis Scholl (UK) Ltd; Seton Schol Ireland Holdings (Republic of systems and the development, support and assembly of Ireland); Seton Scholl European Holdings BV (Netherlands); diagnostic telepathology workstations and the supply of a Seton Scholl International Ireland (Republic of Ireland); Board of Directors: B K H Shah (Chairman and Managing range of chemicals, consumables, provision of specialist Simco Ltd; Sonet Investments Ltd; Sonet Prebbles Ltd; pathology services, laboratory instruments and software Sonet Scholl Overseas Investments Ltd; Sonet Scholl UK Management: Mrs D K Shah (Manager), Mrs K Shah (Secre- for histopathology laboratories. Manufacture and supply of Ltd; SSL Americas Inc (USA); SSL Australia Pty Ltd (Aus- tary), M H Shah (Finance Director), Mrs J Shah (Manager) infection and contamination control products to the hospital tralia); SSL Canada Inc (Canada); SSL Czeska Republika Senior Executives: K H Shah (Company Secretary) and pharmaceutical industry and dermatology sro (Czech Republic); SSL Healthare Italia SpA (Italy); SSL PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals Mergers and Acquisitions: In April 2007 Source BioScience Healthcare Brands SA (Spain); SSL Healthcare Danmark Principal Banks: National Westminster Bank plc plc acquired 40% of the ordinary share capital of the private A/S (Denmark); SSL Healthcare Deutschland GmbH & Co healthcare provider Number One Health Group Limited. In KG (Germany); SSL Healthcare France SA (France); SSL July 2007 Source BioScience plc completed the acquisition Healthcare GmbH (Germany); SSL Healthcare (Hong Kong) of the entire ordinary share capital of Geneservice Limited.
Ltd (Hong Kong SAR); SSL Healthcare Hong Kong Ltd (Hong Subsidiary Companies: (100% owned unless stated): Fair- Kong SAR); SSL Healthcare Ireland Ltd (Republic of Ire- field Imaging Ltd; Fairfield Telepathology Ltd; Geneservice land); SSL Healthcare Japan Ltd (Japan); SSL Healthcare Ltd (75%); Kinetic Imaging Ltd; Medical Solutions FZ LLC SKYEPHARMA PLC
Nederland BV (Netherlands); SSL Healthcare (Norge) A/S (United Arab Emirates); Medical Solutions (London) Ltd (Norway); SSL Healthcare Oesterreich GmbH (Austria); (75%); Medical Solutions (Nottingham) Ltd (75%); Pathlore SSL Healthcare (Polska) Sp zoo (Poland); SSL Healthcare Ltd; Second Opinion Solutions AS (75.3%) (Norway) Singapore Pte Ltd (Singapore); SSL Healthcare Suisse SA Associated Companies: Number One Health Group Ltd (40%) (Switzerland); SSL Healthcare Thailand Ltd (Thailand); SSL Principal Banks: The Royal Bank of Scotland plc Hellas SA (Greece); SSL Holdings Inc (USA); SSL Mag- yarorszag Kft (Hungary); SSL Manufacturing (Thailand) Board of Directors: Jeremy Scudamore (Chairman), Frank Ltd (Thailand); SSL New Zealand Ltd (New Zealand); SSL Condella (Chief Executive Officer), Alan Bray (Non-Executive Products Ltd; SSL Romania SRL (Romania); SSL Slovnsko Director), Dr Ken Cunningham (Chief Operating Officer), Pe- spol sro (Slovakia); SSL Sverige AB (Sweden); SSL-TTK Ltd ter Grant (Finance Director), Stephen Harris (Non-Executive (51%) (India); TTK-LIG Ltd (49.87%) (India); Tubifoam Ltd Director), Dr Argeris Karabelas (Non-Executive Director), Principal Shareholders: Aberforth Partners (15.68%); Mr John Murphy (Company Secretary), Jean-Charles Tschudin S Varkey (8.65%); Mr J Mellon (5.72%); Texas Holdings PRINCIPAL ACTIVITIES: Research, development, manufacture Principal Law Firm: Allen & Overy; Hammonds Financial Information: Consolidated figures Divestments: In March 2007 the Group disposed of its In- Trade Names: Paxil CR, Xatral OD, Madopar DR, Coruno, Sales turnover
Nifedipine, Diclofenac, Dilacor XR, Requip, Statin NK-104, Principal Shareholders: Blackrock Inc (14.94%); Liontrust Foradil DPI, Formoterol HFA, Pulmicort HFA, Formoterol Investment Services Ltd (5.51%); FMR Corp (5.03%) Combi, DepoCyt, DepoMorphine, DepoBupivacaine, Psorax- ine, Interferon alpha-2b, HGH, Solareze, Hyclinda, Acyclovir, Financial Information: Consolidated figures Propofol IDD-D, Busulfan, Fenofibrate, Multiple Subsidiary Companies: (100% owned unless stated): Jago Holding AG (Switzerland); Jagotec AG (Switzerland); Sales turnover
Krypton Ltd (Gibraltar); SkePharma AG (Switzerland); SkePharma Canada Inc (Canada); SkyePharma AB (Swe- SSL INTERNATIONAL PLC
den); SkyePharma Holding AG (Switzerland); SkyePharma Address: 35 New Bridge Street, London EC4V 6BW Holding Inc (USA); SkyePharma (Jersey) Ltd; SkyePharma Production SAS (France); SkyePharma US Inc (USA) Alphabetical Index
Alphabetical
Alphabetical Index
Abbott Laboratorios Lda [Portugal ] 02605 A S Bugshan & Bros [Saudi Arabia] 00326 Index by Country
Getz Bros & Co (Singapore) Pte Ltd 01273 Said Mohamed Obaid Binzagr & Co 00352

Source: http://gale.cengage.co.uk/images/2009%20PHARMBIO%20SAMPLES.pdf